Evidence map›Paper›PMID 18628938›Full record

ArticlePloS one2008

Analysis of Venezuelan equine encephalitis replicon particles packaged in different coats.

Kurt I Kamrud, Kim D Alterson, Chasity Andrews, Laura O Copp, Whitney C Lewis, Bolyn Hubby, Deepa Patel, Jonathan O Rayner, Todd Talarico, Jonathan F Smith

Open access · goldAbstract read
In one paragraph

Article in PloS one, 2008. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 7 papers.

0numbers the graph read from it
0cells of the map it votes in
7citing papers in PubMed
1.6field-weighted citation impact, top 16% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

7 citing papers in PubMed, 13 citations in OpenAlex.

  1. Review
  2. Review
  3. Article
  4. Article
  5. Review
  6. Article
  7. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors at 3 institutions in 1 country.

Kurt I KamrudAlphaVax, Inc., Research Triangle Park, North Carolina, United States of America. kamrud@alphavax.com
Kim D Alterson
Chasity Andrews
Laura O Copp
Whitney C Lewis
Bolyn Hubby
Deepa Patel
Jonathan O Rayner
Todd Talarico
Jonathan F Smith
AlphaVax (United States) · USLiquidia Technologies (United States) · USMRIGlobal · US

Funding

Alphavirus Replicon Vaccines against Marburg VirusU01AI053876 · NIAID · ALPHAVAX HUMAN VACCINES, INC. · PI SMITH, JONATHAN FOWLER · 2002 to 2006
$6.5M
NIAID NIH HHS 5U01AI53876-02NIAID NIH HHS U01 AI053876
6 · The paper itself

Abstract

backgroundThe Venezuelan equine encephalitis (VEE) virus replicon system was used to produce virus-like replicon particles (VRP) packaged with a number of different VEE-derived glycoprotein (GP) coats. The GP coat is believed to be responsible for the cellular tropism noted for VRP and it is possible that different VEE GP coats may have different affinities for cells. We examined VRP packaged in four different VEE GP coats for their ability to infect cells in vitro and to induce both humoral and cellular immune responses in vivo. METHODOLOGY/PRINCIPAL

findingsThe VRP preparations were characterized to determine both infectious units (IU) and genome equivalents (GE) prior to in vivo analysis. VRP packaged with different VEE GP coats demonstrated widely varying GE/IU ratios based on Vero cell infectivity. BALB/c mice were immunized with the different VRP based on equal GE titers and the humoral and cellular responses to the expressed HIV gag gene measured. The magnitude of the immune responses measured in mice revealed small but significant differences between different GP coats when immunization was based on GE titers. CONCLUSIONS/SIGNIFICANCE: We suggest that care should be taken when alternative coat proteins are used to package vector-based systems as the titers determined by cell culture infection may not represent accurate particle numbers and in turn may not accurately represent actual in vivo dose.

Indexed as

RepliconAnimalsEncephalitis Virus, Venezuelan EquineEncephalomyelitis, Venezuelan EquineEnzyme-Linked Immunosorbent AssayFemaleGenetic VectorsGenomeGlycoproteinsImmune SystemMiceMice, Inbred BALB CMutationReverse Transcriptase Polymerase Chain ReactionGlycoproteins

Identifiers

PMID18628938
PMCPMC2447172
OpenAlexW2011605089

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.